Revised nucleic acid test window periods: Applications and limitations in organ donation practice
Transplant Infectious Disease · 2024-02 · 26 (1)
DOI: 10.1111/tid.14180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Infectious Disease, online erschienen am 27.10.2023. Verfasst von Martin Dutch und 3 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Department, Royal Melbourne Hospital, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: HIV Infections, Tissue and Organ Procurement, Hepatitis C. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Nucleic acid test window periods for HIV, HCV, and HBV facilitate estimation of the residual risk of unexpected disease transmission and assist clinicians in determining the timeframe in which a recently acquired infection is at risk of nondetection.
Objectives
Firstly, to provide revised estimates of the NAT window periods based on a currently used triplex NAT assay. Secondly, to examine their validity in organ donation and transplantation practice.
Method
Estimates were based on the Procleix Ultrio Elite Assay (Grifols Diagnostic Solutions Inc. California, USA). The manufacturer's X50 and X95 limits of detection (LOD) were utilised. Viral doubling times of 0.85, 0.45, and 2.56 days and conversion factors for IU per ml to copies per mL of 0.6, 3.4, and 5 were assumed for HIV, HCV, and HBV respectively. Window periods were derived from the X50 and X95 LODs, based on a range of potential inoculum volumes.
Results
Calculated X50 window periods were 5.1 (4.5–5.8), 2.7 (2.4–2.9), and 16.6 (14.2–19.1) days for HIV, HCV, and HBV respectively. Calculated X50 window periods, based on whole body plasma volume, were 11.8 (10.3–13.3), 6.2 (5.6–6.8) and 36.7 (31.3–42.1) days respectively.
Conclusion
X50 NAT window periods were significantly shorter for HBV and HCV and sit at the lower range of previously published estimates for HIV . Current modeling assumptions may not account for all unexpected transmission events and may no longer be suitable for application to organ donation and transplantation. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Emergency Department, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
- Department of Critical Care, University of Melbourne, Melbourne, Victoria, Australia.
- Pathology and Clinical Governance, Australian Red Cross Lifeblood, West Melbourne, Victoria, Australia.
- Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Prahran, Victoria, Australia.
ORCID-Profile: Martin Dutch, Anthea Cheng
Zitieren
APA
Dutch, M., Cheng, A., Kiely, P., & Seed, C. (2024). Revised nucleic acid test window periods: Applications and limitations in organ donation practice. Transplant Infectious Disease, 26(1). https://doi.org/10.1111/tid.14180
Vancouver
Dutch M, Cheng A, Kiely P, Seed C. Revised nucleic acid test window periods: Applications and limitations in organ donation practice. Transplant Infectious Disease. 2024;26(1). doi:10.1111/tid.14180
BibTeX
@article{Dutch2024,
author = {Dutch, Martin and Cheng, Anthea and Kiely, Philip and Seed, Clive},
title = {Revised nucleic acid test window periods: Applications and limitations in organ donation practice},
journal = {Transplant Infectious Disease},
year = {2024},
volume = {26},
number = {1},
doi = {10.1111/tid.14180}
}
EUVIMED